Prominent chemopreventive and chemoenhancing effects for resveratrol: unraveling molecular targets and the role of C-reactive protein.
El-Mowafy
A M
AM
Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. aelmowafy@yahoo.com
El-Mesery
M E
ME
Salem
H A
HA
Al-Gayyar
M M
MM
Darweish
M M
MM
D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism* / Q000502:physiology; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy / Q000517:prevention & control*; D002945:Cisplatin / Q000627:therapeutic use; D005260:Female; D007958:Leukocyte Count; D008315:Malondialdehyde / Q000378:metabolism; D051379:Mice; D000077185:Resveratrol; D013267:Stilbenes / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D016588:Anticarcinogenic Agents; D013267:Stilbenes; D014409:Tumor Necrosis Factor-alpha; D008315:Malondialdehyde; D002097:C-Reactive Protein; D002945:Cisplatin; D000077185:Resveratrol